CNR Institutional Research Information System

BONINI, SERGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.396
NA - Nord America 855
EU - Europa 279
SA - Sud America 219
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.760
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 811
SG - Singapore 583
CN - Cina 317
BR - Brasile 185
HK - Hong Kong 156
VN - Vietnam 151
FR - Francia 98
IT - Italia 63
KR - Corea 62
BD - Bangladesh 32
GB - Regno Unito 28
DE - Germania 27
IN - India 22
JP - Giappone 21
CA - Canada 19
NL - Olanda 16
MX - Messico 13
AR - Argentina 11
FI - Finlandia 11
IQ - Iraq 9
ID - Indonesia 8
IL - Israele 8
EC - Ecuador 7
RU - Federazione Russa 7
SA - Arabia Saudita 6
PK - Pakistan 5
AT - Austria 4
CL - Cile 4
ES - Italia 4
HN - Honduras 4
VE - Venezuela 4
CO - Colombia 3
IE - Irlanda 3
PH - Filippine 3
PY - Paraguay 3
SE - Svezia 3
TH - Thailandia 3
UA - Ucraina 3
AL - Albania 2
AZ - Azerbaigian 2
BS - Bahamas 2
EG - Egitto 2
GR - Grecia 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
MA - Marocco 2
PL - Polonia 2
TN - Tunisia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
CR - Costa Rica 1
EE - Estonia 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
LT - Lituania 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 2.760
Salva come PNG Salva come JPEG
Città #
Santa Clara 366
Singapore 335
Hong Kong 155
Hefei 153
San Jose 77
Ashburn 66
Seoul 62
Lauterbourg 55
Ho Chi Minh City 51
Beijing 50
Hanoi 39
New York 34
São Paulo 20
Los Angeles 17
Frankfurt am Main 15
Tokyo 12
Dallas 10
Minamishinagawa 9
Rio de Janeiro 8
Rome 8
Bengaluru 7
Buffalo 7
Da Nang 7
Haiphong 7
Helsinki 7
Milan 7
Montreal 7
Naples 7
Biên Hòa 6
Guangzhou 6
Bexley 5
Boardman 5
Council Bluffs 5
Düsseldorf 5
Orangeburg 5
Orem 5
Porto Alegre 5
Agawam 4
Baghdad 4
Belo Horizonte 4
Can Tho 4
Curitiba 4
Guayaquil 4
Lahore 4
Newark 4
Portsmouth 4
Salvador 4
São Gonçalo 4
Trento 4
Vienna 4
Brasília 3
Buenos Aires 3
Campinas 3
City of London 3
Cleveland 3
Denver 3
Dhaka 3
Dublin 3
Elk Grove Village 3
Ha Long 3
Houston 3
Imola 3
Jeddah 3
Lappeenranta 3
London 3
Modena 3
Mumbai 3
Nuremberg 3
Omaha 3
Phoenix 3
Roubaix 3
Santiago 3
Toronto 3
Albuquerque 2
Alexandria 2
Anápolis 2
Arcadia 2
Atlanta 2
Baku 2
Betim 2
Bizerte 2
Bragança Paulista 2
Brescia 2
Brooklyn 2
Bắc Giang 2
Bắc Ninh 2
Cairo 2
Caracas 2
Cardiff 2
Catanduva 2
Chicago 2
Chino 2
Cotia 2
Escondido 2
Florianópolis 2
Fortaleza 2
Gilroy 2
Hoàng Mai 2
Huntington 2
Hưng Yên 2
Totale 1.820
Salva come PNG Salva come JPEG
Nome #
Annotated guidance to the European Medicines Agency (EMA) guidelines and regulatory documents. A new series of the BJCP 145
Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products 81
Nerve growth factor (NGF) and lenses: effects of NGF in an in vitro rat model of cataract 77
International consensus on allergy immunotherapy 75
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals--EAACI recommendations 70
Androgen receptor expression during C2C12 skeletal muscle cell line differentiation 68
Exercise-induced hypersensitivity syndromes in recreational and competitive athletes: a PRACTALL consensus report (what the general practitioner should know about sports and allergy). 66
AQUA: Allergy Questionnaire for Athletes. Development and validation 61
Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma 60
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology 57
Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN. 54
Molecular diagnosis and the Italian board for ISAC 52
In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan--An EAACI position paper 51
Nerve growth factor release by human synovial fibroblasts prior to and following exposure to tumor necrosis factor-alpha, interleukin-1 beta and cholecystokinin-8: the possible role of NGF in the inflammatory response. 49
Is epithelial barrier hypothesis the key to understanding the higher incidence and excess mortality during COVID-19 pandemic? The case of Northern Italy 49
Effect of exogenous administration of nerve growth factor in the retina of rats with inherited retinitis pigmentosa. 49
Efficacy of topical nerve growth factor treatment in dogs affected by dry eye. 49
Predictive value of allergy and pulmonary function tests for the diagnosis of asthma in elite athletes. 48
Asthma, allergy and the Olympics: a 12-year survey in elite athletes 48
Prioritizing research challenges and funding for allergy and asthma and the need for translational research--The European Strategic Forum on Allergic Diseases 47
Conjunctival expression of thymosin-â4 in vernal keratoconjunctivitis. 46
MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence 46
Perspectives in allergen immunotherapy: 2019 and beyond 44
Barriers to new drug development in respiratory disease 44
Severe Chronic Allergic (and related) Diseases: a uniform approach- a MeDALL- GA(2)LEN-ARIA Position Paper 43
Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project. 42
Inhibitor of Fatty Acid Amide Hydrolase - Learning from Tragic Failures REPLY 40
International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics 40
Biosimilars and drug development in allergic and immunologic diseases 40
A novel adaptive design for allergen immunotherapy clinical trials 39
Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update 38
Nerve growth factor effect on human primary fibroblastic-keratocytes: Possible mechanism during corneal healing. 38
Building bridges for innovation in ageing: Synergies between Action Groups of the EIP on AHA 38
A case-control study of the relation between plasma selenium and asthma in European populations: a GAL2EN project. 37
Perspectives in allergen immunotherapy: 2017 and beyond 37
Low Levels of Cytokines and Growth Factors in Serum of Allergic and Non-Allergic Top Atletes 36
The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases 35
TLR4 and TLRp expression in different phenotypes of rhinitis 34
Nerve Growth Factor Regulates The Production of Lung Mucins in a Transgenic Mice Model of Asthma. 34
Medical devices in allergy practice 34
Feasibility and challenges of independent research on drugs: the Italian medicines agency (AIFA) experience 34
State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: a position paper of the European Academy of Allergy and Clinical Immunology (EAACI) 32
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group 31
Nonspecific provocation of target organs in allergic diseases: EAACI-GA(2)LEN consensus report. 30
Epidemiological study on allergy and asthma phenotypes: subclinical and severe asthma. 30
Nerve growth factor modulates in vitro the expression and release of TGF-beta1 by amniotic membrane. 30
COVID-19 Clinical trials: Quality matters more than quantity 30
A survey of clinical features of allergic rhinitis in adults 29
Bridging allergologic and botanical knowledge in seasonal allergy: a role for phenology 29
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper 29
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: An EAACI Position Paper 29
The pro-fibrogenic effect of nerve growth factor on conjunctival fibroblasts is mediated by transforming growth factor-beta. 29
Allergy and Clinical Immunology Services in Europe 28
Clinical relevance is associated with allergen-specific wheal size in skin prick testing 28
Low- versus high-baseline epinephrine output shapes opposite innate cytokine profiles: presence of Lewis- and Fischer-like neurohormonal immune phenotypes in humans? 28
The added value of allergen microarray technique to the management of poly-sensitized allergic patients. 28
Allergy and the eye. 27
The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA(2)LEN review 26
Allergic bronchial airway inflammation in nerve growth factor (NGF)-deprived rats: evidence suggesting a neuroimmunomodulatory role of NGF. Exp 25
Sublingual immunotherapy: World Allergy Organization position paper 2013 update 25
Neuropeptide y induces potent migration of human immature dendritic cells and promotes a Th2 polarization 23
EIB or not EIB? That is the question. 23
Innovative medicines: New regulatory procedures for the third millennium 22
An allergist is the new Executive Director of the European Medicine Agency 22
Nerve growth factor and tissue repair remodeling: trkANGFR and p75NTR, two receptors one fate 20
The elite athlete: yes, with allergy we can. 19
Transparency and the Eropean Medicines Agency- Sharing of Clinical Trial Data 18
Lifestyle, sports activities and allergic diseases 17
Totale 2.782
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.450
article - articoli 9.259
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.709
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202435 0 0 0 0 0 0 0 0 6 11 10 8
2024/20251.046 7 2 71 35 294 76 1 41 13 41 241 224
2025/20261.646 81 158 138 235 339 42 235 80 89 109 63 77
2026/202755 55 0 0 0 0 0 0 0 0 0 0 0
Totale 2.782